RNA

Total RNA was prepared from cell line WM3311. These cells are known to have mutations in GRIN2A, PRDM1, TERT, and are upregulated in Notch2. These cells are different from many melanoma cell lines in that they lack the common V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This cell line is wild type for BRAF, N-RAS, c-KIT, and CDK4. WM3311 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM3311. These cells are known to have mutations in GRIN2A, PRDM1, TERT, and are upregulated in Notch2. These cells are different from many melanoma cell lines in that they lack the common V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This cell line is wild type for BRAF, N-RAS, c-KIT, and CDK4. WM3311 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM3406. WM3406 is a human metastatic melanoma cell line that displays a mesenchymal morphology. This cell line contains a Q61K mutation at position 61 in the N-RAS gene which causes increased signaling via the extracellular signal-regulated MAPK/ERK kinase pathways to enhance proliferation. This cell line also expresses mutated PTEN gene and is wild type for BRAF, c-KIT and CDK4. WM3406 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM3406. WM3406 is a human metastatic melanoma cell line that displays a mesenchymal morphology. This cell line contains a Q61K mutation at position 61 in the N-RAS gene which causes increased signaling via the extracellular signal-regulated MAPK/ERK kinase pathways to enhance proliferation. This cell line also expresses mutated PTEN gene and is wild type for BRAF, c-KIT and CDK4. WM3406 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM3406. WM3406 is a human metastatic melanoma cell line that displays a mesenchymal morphology. This cell line contains a Q61K mutation at position 61 in the N-RAS gene which causes increased signaling via the extracellular signal-regulated MAPK/ERK kinase pathways to enhance proliferation. This cell line also expresses mutated PTEN gene and is wild type for BRAF, c-KIT and CDK4. WM3406 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM3438. WM3438 is a human metastatic melanoma cell line that displays a mesenchymal morphology. This cell line contains wild type BRAF, N-RAS, c-KIT and CDK4 genes. WM3438 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM3438. WM3438 is a human metastatic melanoma cell line that displays a mesenchymal morphology. This cell line contains wild type BRAF, N-RAS, c-KIT and CDK4 genes. WM3438 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM3438. WM3438 is a human metastatic melanoma cell line that displays a mesenchymal morphology. This cell line contains wild type BRAF, N-RAS, c-KIT and CDK4 genes. WM3438 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM3456. WM3456 is a human metastatic melanoma cell line that displays a thin elongated, fibroblastic morphology. This cell line contains a Q61K mutation at position 61 in the N-RAS gene which causes increased signaling via the extracellular signal-regulated MAPK/ERK kinase pathways to enhance proliferation.  WM3456 cells produce xenograft tumors when injected into immunocompromised mice.